| Name | interferon (protein family or complex) |
|---|---|
| Synonyms | Interferon |
| Name | griseofulvin |
|---|---|
| CAS |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 11699619 | Andersen V, Sonne J, Andersen M: Spontaneous reports on drug-induced pancreatitis in Denmark from 1968 to 1999. Eur J Clin Pharmacol. 2001 Sep;57(6-7):517-21. A possible or probable causality was considered for a further 30 drugs including 5- agents, angiotensin-converting enzyme inhibitors, preparations, didanosine, antiviral agents used in acquired immunodeficiency syndrome therapy, various lipid-reducing agents, interferon, griseofulvin, ticlopine, allopurinol, lithium and the MMR (measles" mumps/rubella) vaccination. |
81(1,1,1,1) | Details |
| 11092127 | Bocker H, Knorre WA: Antibiotica research in Jena from penicillin and nourseothricin to interferon. Adv Biochem Eng Biotechnol. 2000;70:35-40. Milestones of antibiotics research and biotechnology in Jena/Thuringia are: 1938--Hans Knoll established a strain collection of microorganisms; 1942--production of penicillin on laboratory scale by Hans Knoll; since 1945--development of industrial production processes for penicillin and streptomycin; 1952--production of BCG-vaccine; since 1956--development of biotechnical processes in the Institute of Microbiology and Experimental Therapy for actinomycin C, oxytetracyclin, erythromycin, paromomycin, turimycin, griseofulvin, nystatin, and nourseothricin, and in the 1980s for streptokinase, staphylokinase, and interferons. |
1(0,0,0,1) | Details |
| 12588488 | Capella GL, Altomare GF: Mycosis on mycosis fungoides: zoophilic dermatophytosis selectively superimposed on pre-existing cutaneous T-cell lymphoma (mycosis fungoides) plaques. Mycoses. 2003 Feb;46(1-2):67-70. Either oral itraconazole or griseofulvin, or topical terbinafine were ineffective until the patient, who was treated with systemic retinoids and interferon-alpha for his CTCL, was shifted from leucocyte to lymphoblastoid interferon. |
7(0,0,1,2) | Details |
| 18624717 | Jin H, Yamashita A, Maekawa S, Yang P, He L, Takayanagi S, Wakita T, Sakamoto N, Enomoto N, Ito M: Griseofulvin, an oral antifungal agent, suppresses hepatitis C virus replication in vitro. Hepatol Res. 2008 Sep;38(9):909-18. The current standard therapy for chronic hepatitis C is based on pegylated interferon (IFN) alpha in combination with ribavirin. |
1(0,0,0,1) | Details |